Search results for "ALZHEIMER"

showing 10 items of 706 documents

Serial position effects in dementia of the Alzheimer type.

1998

<b>Background: </b>The aim of the present study was to analyse serial position effects for immediate and delayed free recall in patients with dementia of the Alzheimer type and controls. <b>Experiment 1:</b> 44 patients with dementia of the Alzheimer-type and 24 non-demented controls were asked for immediate and delayed free recall of 12 schematic drawings of common objects presented at the rate of 10 s/picture. Steep primacy effects were obtained at all delays in controls. By contrast, primacy effects were significantly impaired in patients with dementia at all delays of recall. Small immediate and delayed recall recency effects were found in both, patients and cont…

Malemedicine.medical_specialtyCognitive NeuroscienceSerial LearningCentral nervous system diseasePhysical medicine and rehabilitationDegenerative diseaseAlzheimer DiseaseReference Valuesmental disordersmedicineReaction TimeDementiaHumansAgedRecallMemoriamedicine.diseaseSerial position effectPsychiatry and Mental healthFree recallPattern Recognition VisualMental RecallFemaleGeriatrics and GerontologyAlzheimer's diseasePsychologyNeuroscienceDementia and geriatric cognitive disorders
researchProduct

Time estimation in Alzheimer's disease and the role of the central executive.

2004

The aim of this study was to evaluate the role of short-term memory and attention in time estimation. For this purpose we studied prospective time verbal estimation in 21 patients with Alzheimer's disease (AD), and compared their performance with that of 21 matched normal controls in two different conditions: during a digit span task and during an attentional task. Results showed that the performance of AD patients was significantly worse than that of the controls; the interaction between group and condition was significant. We suggest a role of attentional-executive functions in prospective time estimation.

Malemedicine.medical_specialtyCognitive NeuroscienceShort-term memoryExperimental and Cognitive PsychologyAudiologyNeuropsychological TestsSeverity of Illness IndexDevelopmental psychologyDegenerative diseaseArts and Humanities (miscellaneous)Alzheimer DiseaseDevelopmental and Educational PsychologyMemory spanmedicineHumansAttentionAgedAged 80 and overWorking memoryCognitive disorderTime perceptionMiddle Agedmedicine.diseaseNeuropsychology and Physiological PsychologyTime PerceptionTask analysisFemaleAlzheimer's diseasePsychologyCognition DisordersBrain and cognition
researchProduct

CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: the AddNeuroMed study.

2010

An important focus in Alzheimer's disease (AD) research is the development of methods for early diagnosis. Despite progress with some other biomarkers, sensitive and specific neuropsychological measures for identifying subjects in the prodromal phase of AD remain the most promising early diagnostic tool. We evaluated the value of the composite score for the Consortium to Establish a Registry for Alzheimer's disease Neuropsychological Battery (CERAD-NB) in Europeans with mild cognitive impairment (MCI) and in control populations. Baseline clinical data were analyzed from 223 healthy elderly and 224 subjects with MCI from the prospective AddNeuroMed study carried out in Finland, France, Greec…

Malemedicine.medical_specialtyComposite scoreNeuropsychological TestsStatistics NonparametricDevelopmental psychologyProdromal phaseAlzheimer DiseaseInternal medicinemental disordersmedicineHumansRegistriesCognitive impairmentAgedAged 80 and overAnalysis of VarianceGeneral NeuroscienceNeuropsychologyGeneral MedicineHealthy elderlyNeuropsychological batteryEuropePsychiatry and Mental healthClinical PsychologyStatus examinationEarly DiagnosisROC CurveFemaleGeriatrics and GerontologyPsychologyCognition DisordersJournal of Alzheimer's disease : JAD
researchProduct

Alzheimer's disease: amino acid levels and brain metabolic status.

2013

Abstract To study brain free amino acids and their relation with dementia we measured, by high-performance liquid chromatography (HPLC), the concentration of eight free amino acids, amines and related compounds. We used temporal cortex (TC) samples obtained from 13 Alzheimer’s disease (AD) patients and an equal number of agematched controls (AC). The patterns of free amino acids, amines and related compounds showed significant quantitative changes in AD conditions with respect to healthy ones. In Alzheimer patients, lower levels of GABA were found in the TC (-57 %). Amino acids glutamate (Glu), and aspartate (Asp) concentrations, also appeared significantly reduced in the TC of AD patients …

Malemedicine.medical_specialtyDermatologyBiologychemistry.chemical_compoundBrain: Temporal cortexAlzheimer DiseaseSettore BIO/10 - BiochimicaInternal medicinemedicineHumansNeurotransmitterAmino AcidsChromatography High Pressure Liquidgamma-Aminobutyric AcidAgedTemporal cortexchemistry.chemical_classificationMethionineGlutamate receptorBrainGeneral Medicinemedicine.diseaseCystathionine beta synthaseAmino acidAmino acidGlutaminePsychiatry and Mental healthEndocrinologychemistryBiochemistryTemporal cortex; Amino acids; Neurotransmitters; [Keywords Alzheimer’s disease; Brain]biology.proteinFemaleKeywords Alzheimer’s diseaseNeurology (clinical)Alzheimer's diseaseTransmethylationNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
researchProduct

Adolescent binge‐ethanol accelerates cognitive impairment and β‐amyloid production and dysregulates endocannabinoid signaling in the hippocampus of A…

2019

Previous research in rodents suggests that the long‐term neurobehavioral disturbances induced by chronic ethanol (EtOH) exposure could be due to endocannabinoid system (ECS) alterations. Moreover, ECS failure has been proposed to mediate the cognitive impairment and β‐amyloid production in Alzheimer disease (AD). Thus, in the present study, we evaluated the effects of adolescent EtOH binge drinking on the cognitive disturbances, hippocampal β‐amyloid levels, and in the ECS expression on a transgenic mouse model (APP/PSEN, AZ) of AD. We exposed AZ and wild‐type mice to a binge‐drinking treatment during adolescence. At 6 and 12 months of age, we evaluated hippocampal‐dependent learning and me…

Malemedicine.medical_specialtyDiacylglycerol lipasehippocampusmedicine.medical_treatmentMedicine (miscellaneous)HippocampusMice TransgenicHippocampusBinge DrinkingMice03 medical and health sciences0302 clinical medicineAlzheimer DiseaseInternal medicinemental disordersGene expressionmedicineAnimalsCognitive DysfunctionPharmacologyAmyloid beta-PeptidesEthanolbiologyWild typeendocannabinoidmedicine.diseaseEndocannabinoid systembinge drinkingMonoacylglycerol Lipases030227 psychiatryMonoacylglycerol lipaseDisease Models AnimalPsychiatry and Mental healthEndocrinologybiology.proteinβ‐amyloidadolescenceFemaleCannabinoidAlzheimer diseaseAlzheimer's disease030217 neurology & neurosurgeryEndocannabinoidsSignal TransductionAddiction Biology
researchProduct

Legal and assistance aspects of Alzheimer's disease: analysis of 100 cases.

2003

Caring for patients with disabling cognitive diseases, such as Alzheimer's disease (AD) and other progressive dementias, has a number of legal and social welfare implications. The two main problems to be discussed with patients and caregivers are the need for a legal guardian and requests for government financial support, both of which depend on the patient's progressive loss of autonomy and increasing need for assistance. In order to study the presence of these two support measures, we considered 100 AD patients (56 women and 44 men) divided in four groups on the basis of the stage of the disease: mild (25), moderate (34) and severe (32), or death (9). We investigated the number of caregiv…

Malemedicine.medical_specialtyFinancing Governmentmedia_common.quotation_subjectSocial WelfareDermatologyDiseaseInterpersonal relationshipLegal GuardiansPower of attorneyAlzheimer DiseaseLegal guardianmedicineDementiaFinancial SupportHumansInterpersonal RelationsPsychiatrymedia_commonAgedGeneral MedicineMiddle Agedmedicine.diseasePsychiatry and Mental healthCaregiversDisease ProgressionFemaleNeurology (clinical)Alzheimer's diseasePsychologyAutonomyNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
researchProduct

Polymorphism in the peroxisome proliferator-activated receptor ? gene influences the risk for Alzheimer?s disease

2003

The peroxisome proliferator-activated receptor alpha (PPAR-alpha) is a member of the steroid hormone super family of ligand-inducible transcription factors, involved in glucose and lipid metabolism. We screened for polymorphisms in the PPAR-alpha gene and detected two known polymorphisms located in exon 5 and intron 7. These polymorphisms were investigated for their possible association with Alzheimer's disease (AD) and for their effect in carriers of an insulin gene (INS) polymorphism. The PPAR-alpha C --G polymorphism in exon 5 (L162V) was associated with AD, in that the V-allele was more frequent in AD patients than in healthy subjects. Further data analysis revealed that carriers of an …

Malemedicine.medical_specialtyGenotypemedicine.medical_treatmentDNA Mutational AnalysisReceptors Cytoplasmic and NuclearBiologyExonGene FrequencyAlzheimer DiseaseInternal medicineGenotypemedicineHumansInsulinGenetic Predisposition to DiseaseGenetic TestingAlleleReceptorAllele frequencyBiological PsychiatryAgedAged 80 and overAmyloid beta-PeptidesPolymorphism GeneticExonsMiddle Agedmedicine.diseasePsychiatry and Mental healthSteroid hormoneEndocrinologyAmino Acid SubstitutionNeurologyFemaleNeurology (clinical)Peroxisome proliferator-activated receptor alphaAlzheimer's diseaseTranscription FactorsJournal of Neural Transmission
researchProduct

A cross-sectional and longitudinal study on the protective effect of bilingualism against dementia using brain atrophy and cognitive measures.

2020

Abstract Background Evidence from previous studies suggests that bilingualism contributes to cognitive reserve because bilinguals manifest the first symptoms of Alzheimer’s disease (AD) up to 5 years later than monolinguals. Other cross-sectional studies demonstrate that bilinguals show greater amounts of brain atrophy and hypometabolism than monolinguals, despite sharing the same diagnosis and suffering from the same symptoms. However, these studies may be biased by possible pre-existing between-group differences. Methods In this study, we used global parenchymal measures of atrophy and cognitive tests to investigate the protective effect of bilingualism against dementia cross-sectionally …

Malemedicine.medical_specialtyLongitudinal studyBrain atrophyRegion-based morphometryNeurologyBilingualismCognitive NeuroscienceCognitive reserveMultilingualismAudiology050105 experimental psychologylcsh:RC346-429lcsh:RC321-57103 medical and health sciences0302 clinical medicineAtrophymedicineHumansDementia0501 psychology and cognitive sciencesLongitudinal StudiesCognitive declinelcsh:Neurosciences. Biological psychiatry. Neuropsychiatrylcsh:Neurology. Diseases of the nervous systemAgedCognitive reserveBilingüismebusiness.industryResearch05 social sciencesBrainMild cognitive impairmentCognitionMiddle AgedAlzheimer's diseasemedicine.diseaseCognitive testCross-Sectional StudiesMalaltia d'AlzheimerNeurologyDementiaFemaleNeurology (clinical)AtrophybusinessAlzheimer’s disease030217 neurology & neurosurgery
researchProduct

Cognitive impairment: classification by 1H magnetic resonance spectroscopy.

2004

1H magnetic resonance spectroscopy (MRS) allows accurate and non-invasive in vivo metabolic study, and is a useful tool for the diagnosis of different forms of dementias. Cognitive impairment pathologies have been almost exclusively studied with MRS by comparison with healthy without a global comparison amongst Alzheimer disease (AD), vascular dementia, mild cognitive impairment (MCI) and major depression patients with cognitive impairment. Whereas decrease of N-acetylaspartate (NAA) and increase myo-Inositol (mI) at different brain locations by 1H MRS are common features of AD, Choline (Cho) alterations have been inconclusive. In our study, 64 patients with cognitive impairment were evalua…

Malemedicine.medical_specialtyMagnetic Resonance Spectroscopychemistry.chemical_compoundPosterior cingulate gyrusInternal medicinemental disordersmedicineCholineDementiaHumansProspective StudiesVascular dementiaCognitive impairmentDepression (differential diagnoses)Agedbusiness.industryMental DisordersMiddle Agedmedicine.diseasenervous systemNeurologychemistryCardiologyFemaleNeurology (clinical)Alzheimer's diseaseProtonsbusinessCognition DisordersArea under the roc curveNeuroscienceEuropean journal of neurology
researchProduct

Movements Execution in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease

2007

We evaluated the relationship between motor and neuropsychological deficits in subjects affected by amnestic Mild Cognitive Impairment (aMCI) and early Alzheimer’s Disease (AD). Kinematics of goal-directed movement of aMCI and AD subjects were compared to those of age-matched control subjects. AD showed a slowing down of motor performance compared to aMCI and controls. No relationships were found between motor and cognitive performances in both AD and aMCI. Our results suggest that the different motor behaviour between AD and aMCI cannot be related to memory deficits, probably reflecting the initial degeneration of parietal-frontal circuits for movement planning. The onset of motor dysfunct…

Malemedicine.medical_specialtyMild Cognitive ImpairmentMotor dysfunctionneuropsychologyNeurosciences. Biological psychiatry. NeuropsychiatryDiseaseAudiologyNeuropsychological TestsMotor behaviourSeverity of Illness Indexbehavioral disciplines and activitiesAlzheimer Diseasemental disordersmedicineReaction TimeHumansBiomechanicsClinical NoteAlzheimer’s DiseaseCognitive impairmentalzheimer's disease mild cognitive impairment kinematicsAgedDemographypointingMovement DisordersNeuropsychologyCognitionGeneral MedicineControl subjectsBiomechanical PhenomenaSeverity of Illness Index; Humans; Alzheimer Disease; Aged; Mental Recall; Cognition Disorders; Demography; Movement Disorders; Neuropsychological Tests; Amnesia; Biomechanics; Female; Male; Reaction TimeNeuropsychology and Physiological PsychologyNeurologykinematicsMental RecallSettore MED/26 - NeurologiaFemaleNeurology (clinical)AmnesiaPsychologyCognition DisordersNeuroscienceMovement planningRC321-571Behavioural Neurology
researchProduct